ANZCTR search results

This trial investigates the effect of hip surgery on sleep apnea severity. We hypothesise that sleep apnea will worsen in the immediate postoperative period, due to factors such as sedative medications, intubation and the requirement to lie on the back after surgery.

This is a nutrition program for women after breast cancer treatment, called The Muscle Mass, Omega-3, Diet, Exercise and Lifestyle (MODEL) Study. Who is it for? You can join this study if you are a woman who is a breast cancer survivor. In other words, you have successfully completed surgery, radiotherapy and/or chemotherapy with no sign of existing disease, and treatment was completed less than 12 months ago. You must be aged from 18 to 80 years. Trial details Participants will be randomly allocated to one of three groups. One group will take a nutritional supplement of 3g/day of Omega-3 fatty acids for 6 months. A second group will take Omega-3 in conjunction with 12 weeks of Cognitive Behavioural Therapy (CBT) healthy eating and exercise education. The third group will undergo the CBT program and take placebo capsules. Participants will be monitored at the start of the program and at 12 and 26 weeks. The study aims to measure any changes in lean body mass, changes in inflammation and changes in quality of life

Uveitis is a term that refers to inflammatory diseases of the eye. Uveitis accounts for about 10% of the legal blindness in developed countries such as Australia and the United States and is roughly comparable to diabetes in terms of years of visual loss. The most severe forms of uveitis have the highest risk of vision loss. One of the common causes of vision loss in uveitis is swelling of the central retina, or “macular oedema”. This is due to the abnormal leakage of fluid from blood vessels within the retina as a result of uncontrolled inflammation. Standard treatments for severe uveitis and associated complications like macular oedema include systemic medication or injections of long acting steroid into, or around the eye. Systemic treatments include steroid tablets or low doses of drugs that are also used in chemotherapy like cyclophosphamide or cyclosporine. These systemic treatments have significant associated side effects and therefore are not ideal, particularly in people who only have uveitis in one eye. Injections of a long acting steroid (triamcinolone) directly into the eye (“intra-vitreally”) is another established treatment modality for some types of uveitis and blinding complications like uveitic macular oedema, particularly in those with uveitis in only one eye. However, there are known side effects of this treatment such as cataract, glaucoma, infection (endophthalmitis) and retinal detatchment. Of these, cataract and glaucoma are by far the most common and, unlike the other complications, are the direct result of the effect of triamcinolone on the eye, rather than being a complication of the injection procedure. Although the visual loss from cataract may be reversed with cataract surgery, visual loss from glaucoma can only be halted with available treatments and not reversed. Therefore patients who have glaucoma, or are known to develop raised intraocular pressures in response to steroid treatment (such as triamcinolone), are not offered this treatment, thereby limiting the available options for the management of their uveitis and/or uveitic macular oedema. Methotrexate is a drug that has been used in chemotherapy but also in low doses to control inflammatory diseases like rheumatoid arthritis in both adults and children. More recently, it has also been used as an injection intravitreally to treat both ocular lymphoma as well as uveitis and uveitic macular oedema. Preliminary studies using methotrexate intravitreally as treatment for severe forms of uveitis and associated sight threatening complications like macular oedema appear promising, without the side effects known to be associated with steroid treatment such as cataract and glaucoma. We therefore have 2 specific aims: Aim 1: To prospectively evaluate the efficacy of intavitreal methotrexate in the treatment of active intermediate, posterior or panuveitis Aim 2: To prospectively evaluate the efficacy of intravitreal methotrexate in the treatment of uveitic macular oedema

Preterm babies with breathing troubles are routinely supported by the use of continuous positive airway pressure (CPAP) via nasal prongs that require taping to the infant’s face and a bonnet to maintain an adequate seal and to keep the prongs in position. This can restrict care, parent-infant cuddles and breast feeding. The prongs also occlude the nose and sometimes cause damage to the nasal septum. Weaning an infant from CPAP may take weeks or months. This is a randomised controlled trial of 2 methods of weaning CPAP support (abrupt or gradual), combined with the use of Heated Humidified High Flow Nasal Cannula (HHFNC) devices or not, making four arms / groups. The purpose of the study is to determine which method of weaning from CPAP is most effective at reducing the length of hospital stay, facilitating infant suck feeding and parent-infant interaction and reducing the intensity of nursing care.

Research in bipolar disorder has suggested that recovery from the illness consists of a three-pronged approach involving medication, information/education about the disorder, and having a plan or strategy to remain well. The current study combines the latter two psychosocial approaches to recovery in bipolar disorder into one intervention. It aims to examine the efficacy of an 8-session group psychoeducation program for adults recently diagnosed with bipolar II disorder that incorporates the development of an individualised comprehensive wellbeing plan across sessions.

Venous thromboembolism (VTE) is a condition that hospitalized patients may be susceptible to and which results in blood clots forming in their legs or in their lungs. The study will examine whether less patients develop clots when a medical guideline is strictly adhered to. VTE or blood clots may occur in patients in hospital because they are not moving around as much as usual or perhaps because they have other illnesses that put them at risk. To try and reduce your chance of developing blood clots during your hospital stay your doctors may treat you with a ‘blood thinning’ medication or they may arrange for you to wear special stockings. There is some controversy about which patients are most likely to benefit from these preventative measures and some new guidelines have been proposed to help doctors decide which patients to treat and who it is safe not to treat. The purpose of this study is to test whether these guidelines work better than the system that is currently in place for making this judgment.

The purpose of this project is to help understand the most effective delivery methods for TMS treatment in Major Depression. Previous research suggests that administration of repetitive Transcranial Magnetic Stimulation (rTMS) in the frontal regions of the brain clearly has antidepressant effects (i.e. it helps people with depression) and that the response to rTMS is clinically significant in some patients. Most research conducted has used stimulation to a single side of the brain (left or right) using rTMS that is applied at either high (5-10 pulses per second) or low frequency (1 pulse per second). Recently we have conducted research that has suggested that we can improve the response to rTMS by combining low and high frequency stimulation types. We have done this when the stimulation is applied across both sides of the brain (high frequency on the left and low frequency on the right) and when we have applied both to the right side of the brain. Both seem more effective than stimulation applied in only one way. However, we have not compared these two methods to see if one is better than the other. That is the purpose of the current research trial.

The most appropriate dosage of the commonly used analgesic and antipyretic medication paracetamol has not been studied in overweight and obese children. Following a dose of paracetamol, we will measure the saliva and blood concentration (obtained from finger-prick or IV cannula) of paracetamol in a group of overweight and obese children, and compare the calculated pharmacokinetic parameters in the overweight/obese population to the normal BMI population, and determine if there are any differences. In addition, we will measure the efficacy of paracetamol in relieving pain and/or fever in each of these patient groups. A subsequant population pharmacokinetic/pharmacodynamic modelling analysis will allow us to simulate what doses are required to maintain overweight and obese children within a target therapeutic range of 10-30mg/L for the longest period of time.

Being overweight is a major risk factor for diabetes. The main purpose of this study is to determine if exercise can reduce this risk for overweight children and adolescents. At entry to the study, participants will be required to complete a 7 day activity record and a 3 day diet history diary. The participant will then be assigned to either an exercise training group, or a control (non-exercise) group. The 8-week exercise program involves attending a gymnasium three days per week for approximately 1 hour each time. The exercise training regime will be fully structured and supervised by experienced exercise physiologists. If a child is initially in the control group, they will be asked to continue with their normal routine for a period of 8 weeks. At the beginning and at the end of each 8 week period subjects will have their blood pressure measured, and will have a test called a glucose tolerance test that involves the insertion of a small intravenous cannula for blood sampling. They will be asked to drink a sugary cola flavoured liquid and following this, blood samples for blood glucose levels, insulin and cardiovascular risk factors will be taken from the cannula. The test takes a total of 3 hours. Other tests will include a special X-ray scan that determines body composition (fat mass and muscle mass) called a DXA scan. A DXA scan requires subjects to lie on their back on a scanning bed for 3-7 minutes and involves a low radiation dose (5% of a standard chest x-ray). This visit will take approximately 1 hour. Following the series of tests outlined above participants will be allocated to the alternate training group for a further 8 week period followed by a series of repeat tests which are identical to the tests outlined above. By comparing the repeat and initial tests, the effect of the training program on fitness, insulin levels and body composition will be determined.

This is a prospective, randomised, controlled pilot study to evaluate the safety and clinical utility (i.e., performance, functional radiographic parameters) of Graftys(R)HBS or Graftys(R)Quickset in the treatment of unstable distal radius fractures, when used with fractures treated by Kirschner wire fixation. The study will enroll a minimum of 10 patients to a maximum of 50 patients per arm requiring treatment of a primary unstable distal radius fracture.